EFG International AG bought a new position in Cigna Group (NYSE:CI - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The fund bought 9,038 shares of the health services provider's stock, valued at approximately $2,491,000.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. BlackRock Inc. boosted its stake in shares of Cigna Group by 3.7% in the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider's stock worth $6,461,457,000 after buying an additional 840,098 shares during the last quarter. State Street Corp increased its position in Cigna Group by 1.8% during the fourth quarter. State Street Corp now owns 12,339,250 shares of the health services provider's stock valued at $3,396,132,000 after acquiring an additional 224,122 shares during the last quarter. Dodge & Cox increased its position in Cigna Group by 19.7% during the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider's stock valued at $3,065,681,000 after acquiring an additional 1,833,389 shares during the last quarter. GQG Partners LLC lifted its holdings in Cigna Group by 14.3% in the fourth quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider's stock valued at $2,136,699,000 after acquiring an additional 972,302 shares during the period. Finally, Geode Capital Management LLC boosted its position in Cigna Group by 0.8% in the fourth quarter. Geode Capital Management LLC now owns 6,051,370 shares of the health services provider's stock worth $1,658,055,000 after purchasing an additional 48,474 shares during the last quarter. 86.99% of the stock is owned by institutional investors.
Insider Buying and Selling
In related news, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. The trade was a 27.52% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Nicole S. Jones sold 19,436 shares of the company's stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the transaction, the insider directly owned 27,256 shares of the company's stock, valued at $7,530,015.12. This represents a 41.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 23,012 shares of company stock valued at $6,386,550. Company insiders own 0.60% of the company's stock.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on CI shares. Cantor Fitzgerald boosted their price target on Cigna Group from $325.00 to $340.00 and gave the company an "overweight" rating in a research note on Friday, May 1st. Guggenheim raised their price objective on shares of Cigna Group from $338.00 to $361.00 and gave the stock a "buy" rating in a report on Friday, July 31st. Weiss Ratings restated a "hold (c)" rating on shares of Cigna Group in a research report on Monday, June 1st. Piper Sandler reduced their target price on shares of Cigna Group from $370.00 to $346.00 and set an "overweight" rating for the company in a report on Wednesday, June 3rd. Finally, UBS Group increased their price target on shares of Cigna Group from $375.00 to $400.00 and gave the stock a "buy" rating in a research report on Friday, May 22nd. Fifteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $339.45.
Read Our Latest Research Report on Cigna Group
Cigna Group Stock Performance
Shares of CI opened at $281.01 on Thursday. The business has a 50-day simple moving average of $283.58 and a two-hundred day simple moving average of $281.51. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47. The stock has a market cap of $74.25 billion, a price-to-earnings ratio of 11.63, a PEG ratio of 0.96 and a beta of 0.29.
Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating analysts' consensus estimates of $7.60 by $0.18. The firm had revenue of $70.04 billion for the quarter, compared to analysts' expectations of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business's quarterly revenue was up 6.7% on a year-over-year basis. During the same period in the previous year, the firm earned $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, analysts expect that Cigna Group will post 30.51 EPS for the current year.
Cigna Group Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group's payout ratio is currently 25.82%.
Cigna Group Company Profile
(
Free Report)
Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report